Evidence map›Paper›PMID 38487252›Full record

ArticleFrontiers in genetics2024

ACPPfel: Explainable deep ensemble learning for anticancer peptides prediction based on feature optimization.

Mingyou Liu, Tao Wu, Xue Li, Yingxue Zhu, Sen Chen, Jian Huang, Fengfeng Zhou, Hongmei Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. CancerPPD2: an updated repository of anticancer peptides and proteins.Database : the journal of biological databases and curation · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mingyou LiuSchool of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Tao WuSchool of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Xue LiSchool of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Yingxue ZhuSchool of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Sen ChenSchool of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Jian HuangSchool of Life Science and Technology, University of Electronic Science and Technology, Chengdu, China.
Fengfeng ZhouSchool of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Hongmei LiuSchool of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Guiyang Medical University · CNChengdu Neusoft University

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancer peptides (ACPs)deep convolutional neural network (DCNN)ensemble learningexplainable learningfeature optimization

Identifiers

PMID38487252
PMCPMC10937565
OpenAlexW4392292681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.